Prestige Consumer Healthcare (PBH) Depreciation and Depletion (2011 - 2017)
Prestige Consumer Healthcare's (PBH) quarterly Depreciation and Depletion came in at $1.7 million in Q1 2017, up 13.33% year-on-year from $1.5 million in Q1 2016, and up 30.77% quarter-over-quarter from $1.3 million in Q4 2016.
Prestige Consumer Healthcare (PBH) Depreciation and Depletion (2011 - 2017) Analysis & Trends
Prestige Consumer Healthcare's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2017.
- On a quarterly basis, Depreciation and Depletion rose 13.33% year-over-year to $1.7 million in Q1 2017; TTM through Mar 2017 was $6.0 million, a 15.38% increase from a year earlier, with the FY2025 full-year figure at $9.7 million, up 18.29% from the prior year.
- Depreciation and Depletion improved to $1.7 million in Q1 2017 per PBH's latest filing, from $1.3 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $1.7 million in Q1 2017 and bottomed at $500000.0 in Q3 2013.
- The 5-year median for Depreciation and Depletion is $1.2 million (2015), against an average of $1.1 million.
- Across the five-year window, Depreciation and Depletion surged 500.0% in 2013 and retreated 9.09% in 2014, its largest moves.
- Year by year, Depreciation and Depletion stood at $1.1 million in 2013, then declined by 9.09% to $1.0 million in 2014, then gained by 20.0% to $1.2 million in 2015, then grew by 8.33% to $1.3 million in 2016, then jumped by 30.77% to $1.7 million in 2017.
- Per Business Quant, the three latest PBH Depreciation and Depletion figures stand at $1.7 million (Q1 2017), $1.3 million (Q4 2016), and $1.5 million (Q3 2016).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 21.60 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Prestige Consumer Healthcare | 2.44 Bn | 2.38 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 1.70 Mn |
| Mar 31, 2017 | 1.70 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.50 Mn |
| Mar 31, 2016 | 1.50 Mn |
| Mar 31, 2016 | 1.50 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Jun 30, 2015 | 1.30 Mn |
| Jun 30, 2015 | 1.30 Mn |
| Mar 31, 2015 | 1.20 Mn |
| Mar 31, 2015 | 1.20 Mn |
| Dec 31, 2014 | 1.00 Mn |
| Dec 31, 2014 | 1.00 Mn |